TC BioPharm (Holdings) plcTT

TC BioPharm (Holdings) plc

0.0190USDR
−0.0009−4.52%
As of today at 16:33 UTC
USD
No trades
See on Supercharts
Market capitalization
‪224.01 K‬USD
‪−7.34 M‬USD
0.00USD
Beta (1Y)
−2.02

About TC BioPharm (Holdings) plc


CEO
Bryan Kobel
Headquarters
Motherwell
Founded
2021
FIGI
BBG0156K9VX2
TC Biopharm (Holdings) Plc is a clinical-stage biopharmaceutical company, which engages in the development of novel immunotherapy products based on its proprietary allogeneic gamma delta T cell platform. The company was founded by Michael Leek and Angela Scott in 2013 and is headquartered in Motherwell, the United Kingdom.
Performance
‪−1,430.00%‬
‪−1,260.00%‬
‪−1,090.00%‬
‪−920.00%‬
‪−750.00%‬
Q2 '21
Q3 '21
Q4 '21
Q1 '24
Q2 '24
‪‪−10.50 M‬‬
‪‪−7.00 M‬‬
‪‪−3.50 M‬‬
‪0.00‬
‪‪3.50 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−2.80 M‬‬
‪‪−2.10 M‬‬
‪‪−1.40 M‬‬
‪‪−700.00 K‬‬
‪0.00‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−2.80 M‬‬
‪‪−2.10 M‬‬
‪‪−1.40 M‬‬
‪‪−700.00 K‬‬
‪0.00‬
Debt level and coverage
Q2 '21
Q3 '21
Q4 '21
Q1 '24
Q2 '24
‪‪−8.00 M‬‬
‪0.00‬
‪‪8.00 M‬‬
‪‪16.00 M‬‬
‪‪24.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Earnings
Next:Feb 26
2021
2022
2023
2024
‪−80.00‬
‪−60.00‬
‪−40.00‬
‪−20.00‬
‪0.00‬
Actual
Estimate

No news here

Looks like there's nothing to report right now

Displays a symbol's price movements over previous years to identify recurring trends.